If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.

It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.

Wiley InterScience

< Previous Abstract  |  Next Abstract >

Save Article to My Profile      Download Citation      Request Permissions

Abstract |  References  |  Full Text: HTML, PDF (Size: 299K)  | Related Articles | Citation Tracking

On the mechanism of α-amylase
Acarbose and cyclodextrin inhibition of barley amylase isozymes
Naïma Oudjeriouat 1 , Yann Moreau 2 , Marius Santimone 1 , Birte Svensson 3 , Guy Marchis-Mouren 1 and Véronique Desseaux 1
  1 IMRN, Institut Méditerranéen de Recherche en Nutrition, Faculté des Sciences et Techniques de St Jérome, Université d'Aix-Marseille, France;   2 IRD, Institut de Recherche pour le Développement, UR081 Gamet c/o CEMAGREF Montpellier, France;   3 Carlsberg Laboratory, Department of Chemistry, Copenhagen Valby, Denmark
Correspondence to V. Desseaux, IMRN case 342, Faculté des Sciences et Techniques, Avenue. Esc. Normandie-Niemen, 13397 Marseille cedex 20, France. Fax: + 33 4 91 28 84 40, E-mail: veronique.desseaux@univ.u-3mr.fr
 

Enzyme: α-amylase [α(1,4)-glucan-4-glucanohydrolase; EC 3.2.1.1].

 

Note: This paper is dedicated to the late Prof. E. Prodanov (Montevideo, Uruguay).

Copyright FEBS, 2003
KEYWORDS
amylose • maltodextrin • acarbose • barley α-amylase • binding site

ABSTRACT

Two inhibitors, acarbose and cyclodextrins (CD), were used to investigate the active site structure and function of barley α-amylase isozymes, AMY1 and AMY2. The hydrolysis of DP 4900-amylose, reduced (r) DP18-maltodextrin and maltoheptaose (catalysed by AMY1 and AMY2) was followed in the absence and in the presence of inhibitor. Without inhibitor, the highest activity was obtained with amylose, kcat/Km decreased 103-fold using rDP18-maltodextrin and 105 to 106-fold using maltoheptaose as substrate. Acarbose is an uncompetitive inhibitor with inhibition constant (L1i) for amylose and maltodextrin in the micromolar range. Acarbose did not bind to the active site of the enzyme, but to a secondary site to give an abortive ESI complex. Only AMY2 has a second secondary binding site corresponding to an ESI2 complex. In contrast, acarbose is a mixed noncompetitive inhibitor of maltoheptaose hydrolysis. Consequently, in the presence of this oligosaccharide substrate, acarbose bound both to the active site and to a secondary binding site. α-CD inhibited the AMY1 and AMY2 catalysed hydrolysis of amylose, but was a very weak inhibitor compared to acarbose.β- and γ-CD are not inhibitors. These results are different from those obtained previously with PPA. However in AMY1, as already shown for amylases of animal and bacterial origin, in addition to the active site, one secondary carbohydrate binding site (s1) was necessary for activity whereas two secondary sites (s1 and s2) were required for the AMY2 activity. The first secondary site in both AMY1 and AMY2 was only functional when substrate was bound in the active site. This appears to be a general feature of the α-amylase family.


(Received 17 March 2003, revised 23 May 2003, accepted 30 June 2003)

DIGITAL OBJECT IDENTIFIER (DOI)
10.1046/j.1432-1033.2003.03733.x About DOI

Related Articles

  • Find other articles like this in Wiley InterScience
  • Find articles in Wiley InterScience written by any of the authors

Wiley InterScience is a member of CrossRef.

Cross Ref Member


FEBS Journal

Virtual Issues

Read our virtual issues on
Molecular Enzymology,
Structural Biology and
Protein Misfolding, Prions and Amyloid.

FEBS Journal

Structured Digital Abstracts now available for articles describing protein-protein interactions.

Read more...

35th FEBS Congress